header
Local cover image
Local cover image
Image from OpenLibrary

Serum periostin as a biomarker for childhood asthma before and after treatment with inhaled corticosteroid / Mohamed Tarek Abdelsamea Mashal ; Supervised Nadia Ahmed Amin Mostafa , Manal Mohamed Wagdy Elmasry , Sarah Ali Zenhom Mohamed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mohamed Tarek Abdelsamea Mashal , 2018Description: 176 P. : charts , facsimiles ; 25cmOther title:
  • دراسة مستوي البريوستين بالدم كعلامة حيوية في الاطفال المصابين بالربو الشعبي قبل و بعد العلاج بالكورتيزون المستنشق [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics Summary: Background : Bronchial asthma is one of the most common chronic conditions affecting children. It is a heterogeneous disease with multiple, overlapping phenotypes. Biomarkers are currently being investigated to better characterize the disease phenotypes and to identify the response to specific targeted therapies. There are some biomarkers for asthma diagnosis but they are often dif{uFB01}cult in clinical use, particularly in pediatric cases. Periostin is an extracellular matrix protein, upregulated in response to IL-4 or IL-13. Serum periostin is expected to be used as a non-invasive biomarker for asthma diagnosis and management.Objectives: The aim of this study is to assess serum level of periostin in children with asthma before and after treatment with inhaled corticosteroid.Patients and methods: This is a comparative study of twenty nine asthmatic children and thirty healthy, non-asthmatic children as a control group. Both two groups aged from 6 to 12 years. Bronchial asthma was diagnosed according to Global Initiative for Asthma (GINA) 2017. Lung function, blood eosinophil counts, total immunoglobulin E (IgE) levels and serum periostin levels were assessed
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2018.Mo.S (Browse shelf(Opens below)) Not for loan 01010110076938000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2018.Mo.S (Browse shelf(Opens below)) 76938.CD Not for loan 01020110076938000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics

Background : Bronchial asthma is one of the most common chronic conditions affecting children. It is a heterogeneous disease with multiple, overlapping phenotypes. Biomarkers are currently being investigated to better characterize the disease phenotypes and to identify the response to specific targeted therapies. There are some biomarkers for asthma diagnosis but they are often dif{uFB01}cult in clinical use, particularly in pediatric cases. Periostin is an extracellular matrix protein, upregulated in response to IL-4 or IL-13. Serum periostin is expected to be used as a non-invasive biomarker for asthma diagnosis and management.Objectives: The aim of this study is to assess serum level of periostin in children with asthma before and after treatment with inhaled corticosteroid.Patients and methods: This is a comparative study of twenty nine asthmatic children and thirty healthy, non-asthmatic children as a control group. Both two groups aged from 6 to 12 years. Bronchial asthma was diagnosed according to Global Initiative for Asthma (GINA) 2017. Lung function, blood eosinophil counts, total immunoglobulin E (IgE) levels and serum periostin levels were assessed

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image